DRESDEN, Germany, July 20, 2020 /PRNewswire/ -- GEMoaB, a biopharmaceutical company focused on the development of next-generation immunotherapies for hard-to-treat cancers, announced today that it has entered into a research collaboration and license agreement with Intellia (Nasdaq: NTLA), a global leader in the field of genome editing treatments.
The companies will conduct joint research to combine GEMoaB's proprietary RevCAR technology platform with Intellia's proprietary genome editing technologies to discover and develop next-generation allogeneic cellular immunotherapies for hard-to-treat cancers and inflammatory diseases. The companies will focus on immunotherapies directed against a selected number of targets.
Under the terms of the agreement, GEMoaB will receive payments for each product based on target reservation and selection, achievement of regulatory, clinical and commercial milestones as well as tiered royalties based on net sales. Intellia will lead the research collaboration, and be responsible for clinical development and commercialization.
"We are very pleased to enter into the agreement with Intellia, which is, similarly to GEMoaB, using its cutting-edge technology to develop breakthrough products for patients with a high unmet medical need," said Armin Ehninger, Ph.D., Chief Scientific Officer at GEMoaB. "Not only does the collaboration reflect the unique optionality of GEMoaB's technological platform, but it will also provide rapid clinical proof-of-concept for RevCAR, our second cellular immunotherapy platform."
Andrew Schiermeier, Ph.D., Intellia's Chief Operating Officer, added, "We are very pleased to work with the talented GEMoaB team, and believe that their RevCAR platform represents a unique and powerful advance in how we think about engineering cell therapies. We are confident that the combined power of GEMoaB's cellular immunotherapy platform and Intellia's numerous and proprietary CRISPR-based approaches to T-cell engineering will accelerate the development of unique and highly-differentiated, genome-edited products for patients with a high unmet medical need."
About GEMoaB
GEMoaB is a privately-owned, clinical-stage biopharmaceutical company that isaiming to become a globally leading, fully integrated biopharmaceutical company. By advancing its proprietary UniCAR, RevCAR and ATAC platforms, the company will discover, develop, manufacture and commercialize next-generation immunotherapies for the treatment of cancer patients with a high unmet medical need.
GEMoaB has a broad pipeline of product candidates in pre-clinical and clinical development for the treatment of hematological malignancies as well as solid tumors. Its clinical stage assets GEM333, an Affinity-Tailored Adaptor for T-Cells (ATAC) with binding specificity to CD33 in relapsed/refractory AML, and GEM3PSCA, an ATAC with binding specificity to PSCA for the treatment of castrate-resistant metastatic prostate cancer and other PSCA expressing late stage solid tumors, are currently investigated in Phase I studies and globally partnered with Bristol-Myers Squibb. A Phase IA dose-finding study of the first UniCAR asset, UniCAR-T-CD123 for treatment of relapsed/refractory AML and ALL is ongoing, UniCAR-T-PSMA against CRPC and other PSMA-expressing late-stage solid tumors, is planned to be tested in a Phase IA study initiated by H2 2020.
Manufacturing expertise, capability and capacity are key for developing cellular immunotherapies for cancer patients. GEMoaB has established a preferred partnership with its sister company Cellex, a world leader in manufacturing hematopoietic blood stem cell products and a leading European CMO for CAR-T cells, co-operating in that area with several large biotech companies.
About UniCAR and RevCAR
GEMoaB is developing rapidly switchable universal CAR-T platforms, UniCAR and RevCAR, to improve the therapeutic window and increase efficacy and safety of CAR-T cell therapies in more challenging cancers, including solid tumors as well as hard-to-treat inflammatory diseases. Standard CAR-T cells depend on the presence and direct binding of cancer antigens for activation and proliferation. An inherent key feature of the UniCAR and RevCAR platforms is a rapidly switchable on/off mechanism enabled by the short pharmacokinetic half-life and fast internalization of soluble adaptors termed targeting modules (TMs). These TMs provide the antigen-specificity to activate UniCAR/RevCAR gene-modified T-cells (UniCAR-T, RevCAR-T) and consist of a highly flexible antigen-binding moiety, linked to a peptide motif recognized by UniCAR-T/RevCAR-T. Different to UniCAR, where the CAR consists of a scFv, RevCAR uses an inert peptide attached to the CAR. RevCAR TMs consist of a highly flexible antigen-binding moiety, linked to a scFv domain binding to the inert peptide attached to the CAR of the RevCAR effector T-cell.
About ATAC
GEMoaB's platform of Affinity-Tailored Adaptors for T-Cells (ATAC) is characterized by high binding affinity to tumor antigens and lower affinity to the CD3 antigen on effector T-cells, preventing T-cell auto-activation in pre-clinical models. Safety and tolerability of the treatment are also increased by the relatively short serum half-life (60 min). The use of fully humanized antibodies reduces the risk of immunogenicity even in case of chronic dosing. Half-life extended ATACs are in pre-clinical development.
More information can be found at http://www.gemoab.com.
For further information please contactJana Fiebiger[emailprotected] Tel.: +49 351 4466-45012
Investor ContactMichael Pehl[emailprotected]Tel.: +49 351 4466-45030
Forward-looking Statements
This announcement includes forward-looking statements that involve risks, uncertainties and other factors, many of which are outside of our control, that could cause actual results to differ materially from the results and matters discussed in the forward looking statements. Forward looking statements include statements concerning our plans, goals, future events and or other information that is not historical information.
The Company does not assume any liability whatsoever for forward-looking statements. The Company assumes that potential partners will perform and rely on their own independent analyses as the case may be. The Company will be under no obligation to update the Information.
Logo - https://mma.prnewswire.com/media/947610/GEMoaB_Logo.jpg
SOURCE GEMoaB
The rest is here:
- Tile Map Service - Wikipedia - December 8th, 2016 [December 8th, 2016]
- New Depression Treatment - Safe & Effective | Nashville TMS - December 18th, 2016 [December 18th, 2016]
- NeuroStar TMS Therapy Depression Treatment - December 22nd, 2016 [December 22nd, 2016]
- TM - Bulbapedia, the community-driven Pokmon encyclopedia - January 13th, 2017 [January 13th, 2017]
- TMS Resources - VA Learning University - January 13th, 2017 [January 13th, 2017]
- The Marketing Store London - TMS - January 25th, 2017 [January 25th, 2017]
- Local sports: RMS, A-TMS win County League titles - Asheboro Courier Tribune - February 7th, 2017 [February 7th, 2017]
- New Jersey Supreme Court Asks Judiciary to Translate More, Implement TMS - Slator (press release) (subscription) - February 7th, 2017 [February 7th, 2017]
- TMW Suite, TruckMate TMS Now Integrate With 123Loadboard ... - Heavy Duty Trucking - February 7th, 2017 [February 7th, 2017]
- Driving a Ferrari at TMS is a solid Valentine's Day present - Fort Worth Star Telegram (blog) - February 7th, 2017 [February 7th, 2017]
- A Sneak Peak into the Future of the TMS Market - Logistics Viewpoints (blog) - February 8th, 2017 [February 8th, 2017]
- TMS wrestlers gear up for conference - Thermopolis Independent Record Homepage - February 9th, 2017 [February 9th, 2017]
- Other Voices: Trying to manage the Amazon effect? Don't ignore your TMS. - Modern Materials Handling - February 9th, 2017 [February 9th, 2017]
- The Zacks Investment Research Upgrades Edap Tms SA (EDAP) to Hold - DailyQuint - February 10th, 2017 [February 10th, 2017]
- First TMS Patient Health Data Management System for US Physicians Launched - Business News Wales - February 14th, 2017 [February 14th, 2017]
- TMS reporter rides along with MUPD on blackout Thursday - Miami Student - February 14th, 2017 [February 14th, 2017]
- Talent management software (TMS) Market Report -Global Industry Analysis, Development, Scope, Share, Trends ... - Satellite PR News (press release) - February 15th, 2017 [February 15th, 2017]
- TMS Jazz Band Puts on Red Hot Performance at Prudential Center ... - TAPinto.net - February 15th, 2017 [February 15th, 2017]
- Trucker Tools' Load Track now integrated with MercuryGate TMS - Commercial Carrier Journal - February 16th, 2017 [February 16th, 2017]
- Review of Price Trends: EDAP TMS SA (NASDAQ:EDAP) - Is stories - February 20th, 2017 [February 20th, 2017]
- TMS Health Solutions Launches New Website February 21, 2017 ... - Satellite PR News (press release) - February 21st, 2017 [February 21st, 2017]
- All I Want for Christmas Is TMS 2K17 - Supply & Demand Chain Executive - February 23rd, 2017 [February 23rd, 2017]
- New non-medicinal treatment helps with depression | WFAA.com - WFAA.com - February 24th, 2017 [February 24th, 2017]
- EDAP TMS S.A. (EDAP) Announces Prelim. Q4 Revenue of EUR10 ... - StreetInsider.com - February 24th, 2017 [February 24th, 2017]
- Tonganoxie police investgating threatening note left in TMS bathroom - The Mirror - February 24th, 2017 [February 24th, 2017]
- TMW Systems appoints Ray West to lead TMS products - Commercial Carrier Journal - February 24th, 2017 [February 24th, 2017]
- TMS' repave, re-profile project should be done by end of next week - Fort Worth Star Telegram - February 24th, 2017 [February 24th, 2017]
- TMS Host Nation's Largets Daytona 500 Watch Party - Speedway Digest (press release) (blog) - February 27th, 2017 [February 27th, 2017]
- TMS Reviews Riverdale Chapter Five, "Heart of Darkness" | The ... - The Mary Sue - February 28th, 2017 [February 28th, 2017]
- TMS boss Gossage: Austin road track doesn't know NASCAR business - Fort Worth Star Telegram - February 28th, 2017 [February 28th, 2017]
- Trucker Tools integrates Load Track platform with Revenova TMS - Commercial Carrier Journal - February 28th, 2017 [February 28th, 2017]
- TMS Announces 2017 Bladesmithing Competition Winners - Newswise (press release) - March 2nd, 2017 [March 2nd, 2017]
- Edap Tms SA (EDAP) Scheduled to Post Earnings on Friday - Sports Perspectives - March 2nd, 2017 [March 2nd, 2017]
- TMS girls basketball wrap up - Thermopolis Independent Record Homepage - March 2nd, 2017 [March 2nd, 2017]
- Trucker Tools' Load Track integrates with Revenova TMS - Fleet Owner - March 3rd, 2017 [March 3rd, 2017]
- A Very Dumb Agreement With Texas Motor Speedway Keeps Racing From The Rest Of The State - Jalopnik - March 4th, 2017 [March 4th, 2017]
- TMS robotics team headed to state - Northeast Mississippi Daily Journal - March 4th, 2017 [March 4th, 2017]
- Brokerages Anticipate Edap Tms SA (EDAP) to Post $0.01 Earnings Per Share - The Cerbat Gem - March 6th, 2017 [March 6th, 2017]
- TMS to host fashion showcase - Troy Daily News - March 7th, 2017 [March 7th, 2017]
- At Satellite 2017, TMS Touts Expanding Satcom Offerings as Multiple Business Units Integrate Satcom Expertise - Business Wire (press release) - March 8th, 2017 [March 8th, 2017]
- TEA Introduces The TMS-5000 - Yahoo Finance - March 8th, 2017 [March 8th, 2017]
- Achieve TMS Open House Event at New Location in Portland ... - Benzinga - March 8th, 2017 [March 8th, 2017]
- MacroPoint Integrates Load Tracking with Oracle TMS - Heavy Duty Trucking - March 9th, 2017 [March 9th, 2017]
- WGS Systems Launches Tactical Management System (TMS) after Inauguration Success - Heliweb Magazine (press release) (registration) (blog) - March 9th, 2017 [March 9th, 2017]
- TMS Installs 2017 Board Members - Newswise (press release) - March 11th, 2017 [March 11th, 2017]
- Aurora Oil & Gas' Successor Australis Quadruples TMS Acreage - Oil and Gas Investor (registration) - March 11th, 2017 [March 11th, 2017]
- At Satellite 2017, TMS Touts Expanding Satcom Offerings as Multiple Business Units Integrate Satcom Expertise - Yahoo Finance - March 12th, 2017 [March 12th, 2017]
- TMS director resigns - Troy Daily News - March 12th, 2017 [March 12th, 2017]
- NASCAR drivers don't know what to expect from TMS' repave - Fort Worth Star Telegram - April 8th, 2017 [April 8th, 2017]
- Erik Jones Ready for Another Graduation at TMS - Speedway Digest (press release) (blog) - April 8th, 2017 [April 8th, 2017]
- NASCAR practice at TMS 4.7.17 - Fort Worth Star Telegram - April 8th, 2017 [April 8th, 2017]
- Kevin Harvick handles TMS' new pavement well with qualifying win - Fort Worth Star Telegram - April 8th, 2017 [April 8th, 2017]
- Edap Tms SA (ADR) (EDAP) Reaches $2.85 After 6.00% Up Move; Tide Point Capital Management LP Upped Its ... - Key Gazette - June 6th, 2017 [June 6th, 2017]
- Runner-up James Hinchcliffe eyeing Victory Lane visit in Texas this year - Fort Worth Star Telegram - June 6th, 2017 [June 6th, 2017]
- Parity is prevalent in IndyCar as series races to its TMS weekend - Fort Worth Star Telegram - June 6th, 2017 [June 6th, 2017]
- TMS, Levy Restaurants Unveiling Hawg Heaven BLT Dawg - Speedway Digest (press release) (blog) - June 6th, 2017 [June 6th, 2017]
- Embarcadero and TMS Software Team Up for Application ... - Business Wire (press release) - June 6th, 2017 [June 6th, 2017]
- TMS Website/Grades - Thurston Middle School - June 6th, 2017 [June 6th, 2017]
- IndyCar's Will Power looks for another strong start on Texas' new surface - Fort Worth Star Telegram - June 7th, 2017 [June 7th, 2017]
- Armstrong & Associates Releases 3Gtms Case Study - GlobeNewswire (press release) - June 7th, 2017 [June 7th, 2017]
- TMS' Hawg Heaven BLT Dawg is a worldly creation - Fort Worth Star Telegram - June 7th, 2017 [June 7th, 2017]
- Slumping Nemechek Sets Sights On Fun At TMS - RacinToday.com - June 8th, 2017 [June 8th, 2017]
- Stadium Super Trucks to create mega buzz at TMS - Fort Worth Star Telegram - June 8th, 2017 [June 8th, 2017]
- What's Happening To These Stocks? EDAP TMS SA (EDAP), Nutanix, Inc. (NTNX) - Post Analyst - June 10th, 2017 [June 10th, 2017]
- TMS Lighting - June 11th, 2017 [June 11th, 2017]
- DAT and Ascend offer free TMS software - Fleet Owner - June 13th, 2017 [June 13th, 2017]
- Keep calm and let the TMS decide - DC Velocity - June 13th, 2017 [June 13th, 2017]
- UCLA doctors use magnetic stimulation to 'rewire' the brain for ... - UCLA Newsroom - June 14th, 2017 [June 14th, 2017]
- TMS students join in Junior Solar Sprint, KidWind Competition - Tallmadge Express - June 21st, 2017 [June 21st, 2017]
- Edap Tms (EDAP) Shares March Higher, Can It Continue? - Zacks.com - June 22nd, 2017 [June 22nd, 2017]
- Zacks Investment Research Upgrades EDAP TMS S.A. (EDAP) to ... - The Cerbat Gem - June 23rd, 2017 [June 23rd, 2017]
- EDAP TMS SA (EDAP) has a mean analyst rating of 2.00 - Stocks Gallery - June 24th, 2017 [June 24th, 2017]
- 'Pokemon Go' Technical Machine: How to Use a TM to Learn a New Move - Heavy.com - June 24th, 2017 [June 24th, 2017]
- Pigeons, buses and mixing up fielders: TMS will miss Henry Blofeld - The Guardian - June 24th, 2017 [June 24th, 2017]
- Is a 'brain massage' the secret to treating depression? - Telegraph.co.uk - June 26th, 2017 [June 26th, 2017]
- Pokemon GO: How to Get and Use TMs - Game Rant - June 26th, 2017 [June 26th, 2017]
- 'Pokmon Go' Charged TM vs. Fast TM: What you need to know about the items added in the raid update - Mic - June 27th, 2017 [June 27th, 2017]
- Financial Analysis: EDAP TMS (EDAP) and Integer Holdings (ITGR) - The Cerbat Gem - June 30th, 2017 [June 30th, 2017]
- Indra To Replatform Its Leading TMS Solutions For Hotels Onto Sap S/4 Hana - Hospitality Net - June 30th, 2017 [June 30th, 2017]
- bob's guide to treasury management systems: How to avoid disruption during TMS implementation - Bobsguide (press release) - June 30th, 2017 [June 30th, 2017]